Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia, Armenia, and South Africa and in a multicountry st...

Full description

Bibliographic Details
Main Authors: Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Eric Caumes, Mathilde Fréchet-Jachym, Jérôme Robert, Nicolas Veziris, Naira Khachatryan, Tinatin Kotrikadze, Armen Hayrapetyan, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2019-05-01
Series:Emerging Infectious Diseases
Subjects:
multidrug resistant
extensively drug resistant
tuberculosis
bedaquiline
individual patient data
tuberculosis and other mycobacteria
Online Access:https://wwwnc.cdc.gov/eid/article/25/5/18-1823_article

Internet

https://wwwnc.cdc.gov/eid/article/25/5/18-1823_article

Similar Items